Exploring the Risk Factors of Otomycosis: A Case-Control Study

ConditionOtomycosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorZhongshan Hospital Xiamen University

About this trial

The goal of this observational study is to explore the risk factors of fungal otitis externa in the fungal otitis externa patients The main question it aims to answer is:

What behaviors lead to the occurrence of fungal otitis externa? Participants will complete a detailed questionnaire survey. If there is a comparison group: Researchers will compare the healthy group and the disease group to see if there are any differences.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Symptoms in the case group include tinnitus, ear fullness or blockage, itching, ear pain, discharge, and hearing loss. Physical examination reveals the presence of hyphae, scabs, secretions, masses, pus, red skin, erosion, swelling, or granulation in the ear canal. Laboratory fungal cultures must be positive. The control group does not have the aforementioned ear symptoms and has not sought medical attention for ear-related symptoms.

Disqualifiers

Patients with otitis media, tympanic membrane perforation, or post-radiotherapy.

Trial population

Our institution is a tertiary first-class comprehensive hospital. Both the disease group and the control group are seen and screened at our facility

Trial design

Design model

Case-control

Time perspective

Retrospective

Treatments tested in this trial

  • exposures

    Other intervention

    exposures: Ear cleaning, swimming, wearing earphones, diabetes, immunosuppression, antibiotic ear drops, narrowing of the external auditory canal, etc.

Treatment groups

200 Participants
are divided into 2 treatment groups
Group A: Case Group1 intervention
Group B: Control Group1 intervention

Trial outcomes

Primary outcomes

1

Odds Ratio

The ratio of exposed to non-exposed individuals in the case group divided by the ratio of exposed to non-exposed individuals in the control group.

Time frame
1month

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.